Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oseroff

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Photochemistry and Photobiology|May 1, 1995
The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA)K Rittenhouse-Diakun, H Van Leengoed, J Morgan, et al.
The Journal of Clinical Investigation|July 1, 1986
Preferential light absorption in atheromas in vitro. Implications for laser angioplastyM R Prince, T F Deutsch, M M Mathews-Roth, et al.
Journal of Medicinal Chemistry|May 27, 2005
Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacyYihui Chen, Xiang Zheng, Mahabeer P Dobhal, et al.
Photochemistry and Photobiology|November 10, 2005
Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacyAndrew Rosenfeld, Janet Morgan, Lalit N Goswami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2Weiguo Liu, Maria R Baer, Mary Jo Bowman, et al.
The Journal of Clinical Investigation|February 1, 1993
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patientsA Valli, A Sette, L Kappos, et al.
Photochemistry and Photobiology|July 1, 1987
Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysisA R Oseroff, G Ara, D Ohuoha, et al.
Archives of Dermatology|January 19, 2005
Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapyAllan R Oseroff, Sherry Shieh, Noreen P Frawley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapyMukund Seshadri, Joseph A Spernyak, Richard Mazurchuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic miceA D Sette, C Oseroff, J Sidney, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Photochemistry and Photobiology|May 1, 1995
The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA)K Rittenhouse-Diakun, H Van Leengoed, J Morgan, et al.
The Journal of Clinical Investigation|July 1, 1986
Preferential light absorption in atheromas in vitro. Implications for laser angioplastyM R Prince, T F Deutsch, M M Mathews-Roth, et al.
Journal of Medicinal Chemistry|May 27, 2005
Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacyYihui Chen, Xiang Zheng, Mahabeer P Dobhal, et al.
Photochemistry and Photobiology|November 10, 2005
Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacyAndrew Rosenfeld, Janet Morgan, Lalit N Goswami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2Weiguo Liu, Maria R Baer, Mary Jo Bowman, et al.
The Journal of Clinical Investigation|February 1, 1993
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patientsA Valli, A Sette, L Kappos, et al.
Photochemistry and Photobiology|July 1, 1987
Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysisA R Oseroff, G Ara, D Ohuoha, et al.
Archives of Dermatology|January 19, 2005
Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapyAllan R Oseroff, Sherry Shieh, Noreen P Frawley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapyMukund Seshadri, Joseph A Spernyak, Richard Mazurchuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic miceA D Sette, C Oseroff, J Sidney, et al.
Pageof 18